To make mini-organs grow faster, give them a squeeze

Study finds that compressing cells, and crowding their contents, can coax them to grow and divide.

Jennifer Chu | MIT News Office • mit
Oct. 13, 2020 ~7 min

Cancer researchers collaborate, target DNA damage repair pathways for cancer therapy

MIT researchers find blocking the expressions of the genes XPA and MK2 enhances the tumor-shrinking effects of platinum-based chemotherapies in p53-mutated cancers.

Koch Institute • mit
Oct. 1, 2020 ~7 min


Gene-controlling mechanisms play key role in cancer progression

Study finds “epigenomic” alterations evolve as lung tumors become more aggressive and metastasize.

Anne Trafton | MIT News Office • mit
July 23, 2020 ~7 min

How cancer drugs find their targets

Certain cancer therapeutics concentrate within cells — a finding that could change the way scientists think about drug design.

Eva Frederick | Whitehead Institute • mit
June 26, 2020 ~10 min

Counting your antigens

A new platform that precisely quantifies antigens presented on cell surfaces may help researchers and clinicians improve the effectiveness of cancer immunotherapies.

Bendta Schroeder | Koch Institute • mit
June 2, 2020 ~9 min

A boost for cancer immunotherapy

Engineers design nanoparticles that stimulate the immune system, helping it to attack tumors.

Anne Trafton | MIT News Office • mit
June 1, 2020 ~7 min

Deep learning accurately stains digital biopsy slides

Pathologists who examined the computationally stained images could not tell them apart from traditionally stained slides.

Becky Ham | MIT Media Lab • mit
May 22, 2020 ~8 min

Making an impact through chemical engineering

Hadley Sikes designs simple-to-use diagnostic devices that could benefit patients around the world.

Anne Trafton | MIT News Office • mit
May 18, 2020 ~7 min


New sensors could offer early detection of lung tumors

Study shows that a simple urine test can reveal the presence of lung cancer in mice.

Anne Trafton | MIT News Office • mit
April 1, 2020 ~7 min

Thank you for your patients

An unusual synergy between cancer researchers, clinical centers, and industry leads to promising clinical trials for a new combination therapy for prostate cancer.

Bendta Schroeder | Koch Institute • mit
March 23, 2020 ~7 min

/

25